PHARMACYTE BIOTECH, INC. (PMCB) Deferred Tax Assets, Investment in Subsidiaries

PHARMACYTE BIOTECH, INC. Deferred Tax Assets, Investment in Subsidiaries

PHARMACYTE BIOTECH, INC. (PMCB) had Deferred Tax Assets, Investment in Subsidiaries of $511.46 thousand as of 2026-04-30, per its 10-K filed 2026-07-29.

Financial Statements › Notes › Income Taxes › Components of Deferred Tax Assets and Liabilities › Components of Deferred Tax Assets › Deferred Tax Assets, Net › Deferred Tax Assets, Net of Valuation Allowance › Deferred Tax Assets, Gross

us-gaap:DeferredTaxAssetsInvestmentInSubsidiaries · last filed 2026-07-29

• 2026-04-30: Deferred Tax Assets, Investment in Subsidiaries $511.46K.
• 2025-04-30: Deferred Tax Assets, Investment in Subsidiaries $0.00.